CAXTON CORP 13D and 13G filings for Strongbridge Biopharma plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-05 12:50 pm Sale | 2021-10-05 | 13D | Strongbridge Biopharma plc SBBP | CAXTON CORP | 0 0.000% | -10,280,682 (Position Closed) | Filing |
| 2020-09-23 10:37 am Purchase | 2020-09-17 | 13D | Strongbridge Biopharma plc SBBP | CAXTON CORP | 10,280,682 15.200% | 1,765,853 (+20.74%) | Filing |